The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer

Autor: Zhao D, Guo L, Neves H, Yuen HF, Zhang SD, McCrudden CM, Wen Q, Zhang J, Zeng Q, Kwok HF, Lin Y

Publikováno v: OncoTargets and Therapy, Vol 2015, Iss default, Pp 1707-1717 (2015)

Duanzheng Zhao,1 Libin Guo,2,* Henrique Neves,3,* Hiu-Fung Yuen,4 Shu-Dong Zhang,5 Cian M McCrudden,6 Qing Wen,5 Jin Zhang,2 Qi Zeng,4 Hang Fai Kwok,3,5,6 Yao Lin2 1College of Continuing Education, Nanjing University of Aeronautics andAstronautics, N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::6c0ae9db5a5499e2d3b557b65963909f
http://www.dovepress.com/the-prognostic-significance-of-protein-tyrosine-phosphatase-4a2-in-bre-peer-reviewed-article-OTT

Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine.

Autor: McCrudden CM; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Bennie L; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Chambers P; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Wilson J; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Kerr M; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Ziminska M; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Douglas H; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Kuhn S; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Carroll E; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., O'Brien G; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK., Buckley N; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Dunne NJ; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK; School of Chemical Sciences, Dublin City University, Collins Avenue, Dublin 9, Ireland; School of Mechanical & Manufacturing Engineering, Dublin City University, Collins Avenue, Dublin 9, Ireland; Advanced Manufacturing Research Centre (I-Form), School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland; Advanced Materials and Bioengineering Research Centre (AMBER), Trinity College Dublin, Dublin 2, Ireland; Biodesign Europe, Dublin City University, Dublin 9, Ireland., McCarthy HO; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; pHion Therapeutics, Catalyst Concourse Building 2, 20 Queens Road, Belfast BT3 9DT, UK; School of Chemical Sciences, Dublin City University, Collins Avenue, Dublin 9, Ireland; Biodesign Europe, Dublin City University, Dublin 9, Ireland. Electronic address: h.mccarthy@qub.ac.uk.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2023 Oct; Vol. 362, pp. 536-547. Date of Electronic Publication: 2023 Sep 09.

Rational design and characterisation of an amphipathic cell penetrating peptide for non-viral gene delivery.

Autor: McErlean EM; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., McCrudden CM; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., McBride JW; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Cole G; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Kett VL; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Robson T; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons Ireland, 111 St Stephen's Green, Dublin 2, UK., Dunne NJ; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland, UK; Centre for Medical Engineering Research, School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland, UK; Department of Mechanical and Manufacturing Engineering, School of Engineering, Trinity College Dublin, Dublin 2, Ireland, UK; Advanced Manufacturing Research Centre (I-Form), School of Mechanical and Manufacturing Engineering, Dublin City University, Glasnevin, Dublin 9, Ireland; Advanced Materials and Bioengineering Research Centre (AMBER), Royal College of Surgeons in Ireland and Trinity College Dublin, Dublin, Ireland, UK; Advanced Processing Technology Research Centre, Dublin City University, Dublin 9, Ireland, UK; Trinity Centre for Biomedical Engineering, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland, UK., McCarthy HO; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; School of Chemical Sciences, Dublin City University, Dublin 9, Ireland, UK.

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2021 Mar 01; Vol. 596, pp. 120223. Date of Electronic Publication: 2021 Jan 27.

NOX4 is a major regulator of cord blood-derived endothelial colony-forming cells which promotes post-ischaemic revascularization.

Autor: O'Neill KM; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Campbell DC; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Edgar KS; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Gill EK; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Moez A; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., McLoughlin KJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., O'Neill CL; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Dellett M; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Hargey CJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Abudalo RA; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., O'Hare M; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Doyle P; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Toh T; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Khoo J; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Wong J; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., McCrudden CM; School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK., Meloni M; Sanofi R&D, 91380 Chilly-Mazarin, France., Brunssen C; Division of Vascular Endothelium and Microcirculation, Department of Medicine III, Medical Faculty and University Clinics Carl Gustav Carus, Technische Universität Dresden, D-01307 Dresden, Germany., Morawietz H; Division of Vascular Endothelium and Microcirculation, Department of Medicine III, Medical Faculty and University Clinics Carl Gustav Carus, Technische Universität Dresden, D-01307 Dresden, Germany., Yoder MC; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA., McDonald DM; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Watson CJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Stitt AW; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Margariti A; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Medina RJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK., Grieve DJ; Centre for Experimental Medicine, Wellcome-Wolfson Institute, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.

Publikováno v: Cardiovascular research [Cardiovasc Res] 2020 Feb 01; Vol. 116 (2), pp. 393-405.

Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide.

Autor: Schiroli D; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland., Gómara MJ; Unit of Synthesis and Biomedical Applications of Peptides, Department of Biomedical Chemistry, Institute for Advanced Chemistry of Catalonia, Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Barcelona, Spain., Maurizi E; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland., Atkinson SD; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland; Northern Ireland Centre for Stratified Medicine, University of Ulster, Londonderry BT47 6SB, UK., Mairs L; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland., Christie KA; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland., Cobice DF; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland., McCrudden CM; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland., Nesbit MA; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland., Haro I; Unit of Synthesis and Biomedical Applications of Peptides, Department of Biomedical Chemistry, Institute for Advanced Chemistry of Catalonia, Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Barcelona, Spain., Moore T; Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, Northern Ireland. Electronic address: tara.moore@ulster.ac.uk.

Publikováno v: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2019 Sep 06; Vol. 17, pp. 891-906. Date of Electronic Publication: 2019 Aug 01.